Blog
Transvaginal Mesh Trial: More Testimony from Johnson & Johnson’s Case in Chief
January 1, 1970 · FLEMING | NOLEN | JEZ, L.L.P.
A number of Ethicon, a Johnson & Johnson company, employees testified this week in the on-going transvaginal mesh trial, as well as, its expert urologist. Here are some highlights from their testimony: Sean O’Bryan, Director of Regulatory Affairs No clinical data on Prolift transvaginal mesh was needed to determine its safety and efficacy. The design process for Prolift transvaginal mesh…
read more
Business as Usual: Johnson & Johnson Puts Profits Over Patient Safety
January 1, 1970 · FLEMING | NOLEN | JEZ, L.L.P.
Within the last two months, we have learned how Johnson & Johnson handles its medical device business. It puts profits over patient safety. Johnson & Johnson has sold and marketed several devices with out obtaining the proper FDA clearance or approval. Clearly, this practice puts patients at risk. Just last month is was reported that Johnson & Johnson sold medical…
read more